Life Science News

Latest updates from the biotech and pharma world

BioPharma Dive 2026-02-03

Pfizer dips on new data for obesity drug acquired in $10B deal

BioPharma Dive 2026-02-03

FDA launches ‘PreCheck’ program; AstraZeneca, Acadia drugs set back

BioPharma Dive 2026-02-02

Novo combination obesity shot meets goal in diabetes trial

BioPharma Dive 2026-02-02

Sanofi drug, inherited from Genzyme, goes 1-for-2 in rare disease trials

BioPharma Dive 2026-02-02

GSK walks away from pioneering Wave RNA editing drug

BioPharma Dive 2026-02-02

Building a robust in-process testing plan for cell therapy manufacturing success

BioPharma Dive 2026-01-30

Amgen gives up on its once-prized eczema drug

BioPharma Dive 2026-01-30

AstraZeneca leans into obesity, striking wide-ranging alliance with China’s CSPC

BioPharma Dive 2026-01-30

Politicization runs deeper than ever at FDA, risking long-term impacts

BioPharma Dive 2026-01-29

The biopharma industry outlook on 2026: Optimism and tension

BioPharma Dive 2026-01-29

Sanofi expects vaccine sales growth to dip amid ‘challenging environment’

BioPharma Dive 2026-01-29

AstraZeneca strengthens China ties with planned $15B investment

BioPharma Dive 2026-01-29

Tenpoint wins FDA nod for combination presbyopia eye drop

BioPharma Dive 2026-01-28

Lilly bets on Seamless, delving further into genetic medicine for hearing loss

BioPharma Dive 2026-01-28

Drugs for cancer, arthritis and HIV on Medicare’s list for 2028 price cuts

BioPharma Dive 2026-01-28

Halozyme buys a biotech startup; Cytokinetics launches heart drug

BioPharma Dive 2026-01-28

Regenxbio gene therapy trials suspended by FDA over safety worries

BioPharma Dive 2026-01-27

FDA lifts hold on an Intellia CRISPR drug trial

BioPharma Dive 2026-01-27

Roche, trailing in obesity, showcases new data for GLP-1 shot

BioPharma Dive 2026-01-27

An immune drug developer raises $50M to finance its eczema drug testing

-245 / 9